Jade Biosciences, Inc. · NASDAQ:JBIO
The Vanguard Group's stake in Jade Biosciences, Inc. fell to 4.24% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group's stake in Jade Biosciences, Inc. fell to 4.24%, 2,095,767 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 4.24%
- Shares
- 2,095,767
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.24% | 2,095,767 |
Source
Related
- Jade Biosciences, Inc.
- The Vanguard Group
- Jade Biosciences, Inc. shareholders
- Schedule 13G · The Vanguard Group · Jul 29, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026